USA. v. Damon, 96-4378

Citation191 F.3d 561
Decision Date07 May 1999
Docket NumberNo. 96-4378,96-4378
Parties(4th Cir. 1999) UNITED STATES OF AMERICA, Plaintiff-Appellee, v. MARVIN J. DAMON, Defendant-Appellant. Argued:
CourtUnited States Courts of Appeals. United States Court of Appeals (4th Circuit)

COUNSEL ARGUED: Stephen Clayton Gordon, FEDERAL PUBLIC DEFENDER'S OFFICE, Raleigh, North Carolina, for Appellant. David John Novak, Assistant United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Richmond, Virginia, for Appellee. ON BRIEF: William Arthur Webb, Federal Public Defender, G. Alan DuBois, Assistant Federal Public Defender, Raleigh, North Carolina, for Appellant. Helen F. Fahey, United States Attorney, OFFICE OF THE UNITED STATES ATTORNEY, Richmond, Virginia, for Appellee.

Before WILLIAMS, MICHAEL, and KING, Circuit Judges.

Remanded by published opinion. Judge Michael wrote the majority opinion, in which Judge King joined. Judge Williams wrote a dissenting opinion.

OPINION

MICHAEL, Circuit Judge:

During Marvin Damon's Rule 11 hearing on the entry of his guilty plea, he told the district court that he was under the influence of an antidepressant drug. The court did not make any inquiry about the drug's effect on Damon, but went on to accept his plea. Damon now challenges the validity of his plea, arguing that the district court had a duty to follow up on the drug ingestion issue in order to determine whether he was competent to plead. We agree. We decline to order that Damon's guilty plea be vacated, however. Instead, we remand for the district court to determine (if it can) whether any drug taken by Damon had the capacity to impair his judgment sufficiently to render him incapable of entering a knowing and voluntary plea.

I.

According to the government, Damon served as an"enforcer" for a heroin distribution ring based in Richmond, Virginia. On October 16, 1995, he was charged (in a third superseding indictment) with various offenses relating to his role in the drug conspiracy, including murder in furtherance of a continuing criminal enterprise in violation of 21 U.S.C. § 848(e)(1)(A). The government filed a notice of intent to seek the death penalty. Thereafter, on January 10, 1996, Damon entered into a plea agreement with the government. He agreed to plead guilty to the federal charge of murder in furtherance of a continuing criminal enterprise and to two additional counts of murder in state court. In exchange for his guilty pleas, the federal government and the Commonwealth of Virginia agreed that they would not seek the death penalty.

On the evening of January 10, 1996, within hours of signing the plea agreement, Damon attempted suicide by trying to hang himself in his jail cell. After he was found unconscious, he was rushed to the hospital, where he was treated and placed under psychiatric observation. He was released from the hospital on January 13, 1996. Later that day, he was taken to district court to enter his guilty plea. When questioned by the court, however, Damon said that he had been under a lot of "pressure and stress" when he signed the plea agreement and that he no longer wanted to plead guilty. He explained that after signing the agreement, "I realized I probably did wrong and that's why I tried to hang myself that night." The district court accepted this explanation and set a date for trial.

Three days later, on January 16, 1996, Damon returned to court. Government counsel explained that Damon had changed his mind and once again wished to accept the plea agreement. The court then began the inquiry of Damon that is required before a guilty plea can be accepted. See Fed. R. Crim. P. 11. The following exchange took place during the court's questioning:

THE COURT: Have you recently been treated for any kind of mental illness or addiction to narcotic drugs?

THE DEFENDANT: I haven't been treated.

THE COURT: Are you currently under the influence of any kind of drug or medication or alcoholic beverage?

THE DEFENDANT: Yes, sir.

THE COURT: What's the nature of the drug?

THE DEFENDANT: Depression.

THE COURT: I can't hear you. You have to speak up.

THE DEFENDANT: Depression.

THE COURT: Antidepressant?

THE DEFENDANT: From the suicide attempt.

THE COURT: Do you know anything about the nature of the drug?

MR. ELIADES [counsel for Damon]: Your Honor, all we have for you is the hospital's records with regards to treatment. I think there is a name of a medication on it, Elantin, or something of that nature.1 And it shows -"impaired judgment" is in the notes, as well as other things. We can provide these to the Court.

THE COURT: All right. Now, Mr. Damon, have you had an adequate opportunity to receive and review a copy of the indictment, the charges against you?

THE DEFENDANT: Yes, sir.

The court did not ask any follow-up questions about whether the medication had any actual effect on Damon's ability to enter a competent and voluntary plea. Instead, the court continued with the usual questions, asking Damon whether he understood the charges against him, whether he was satisfied with the efforts of his lawyers, whether he understood the terms of the plea agreement, and whether he understood the consequences of his guilty plea. Damon answered these questions in the affirmative. The court also asked his lawyers if they knew of any reason why Damon would not be competent to enter a plea of guilty. The lawyers said they knew of no such reason. The court then accepted Damon's guilty plea, finding that he was competent to enter a plea and that he understood the nature of the charges and the consequences of his plea. On April 30, 1996, the district court sentenced Damon to life imprisonment. Damon made a pro se motion to vacate his plea on May 9, 1996, contending, among other things, that he lacked the capacity to make an intelligent plea because of the medication. The district court denied the motion the next day without comment. Damon immediately appealed his conviction and sentence, challenging only the validity of his guilty plea.

II.
A.

Damon contends that the district court had a duty, when informed that he was under the influence of medication, to make further inquiry into his competence to plead guilty. Otherwise, Damon argues, the court could not determine that his plea was knowing and voluntary. We agree.2 Before a court may accept a guilty plea, it must ensure that the defendant is competent to enter the plea. See Godinez v. Moran, 509 U.S. 389, 400 (1993). The court must also determine that the plea is knowing and voluntary. See id.

Rule 11 of the Federal Rules of Criminal Procedure was adopted to standardize the process for accepting guilty pleas in federal court. This rule provides that the court must personally inform the defendant of, and ensure that he understands, the nature of the charges against him and the consequences of his guilty plea. Rule 11 has two principal purposes. First, it "assist[s] the district judge in making the constitutionally required determination that a defendant's guilty plea is truly voluntary." McCarthy v. United States, 394 U.S. 459, 465 (1969). Second, it "produce[s] a complete record at the time the plea is entered of the factors relevant to this voluntariness determination." Id.

Two of our sister circuits require additional inquiry by a district court once a defendant seeking to enter a guilty plea has stated that he is under the influence of drugs. In United States v. Cole, 813 F.2d 43, 47 (3d Cir. 1987), the Third Circuit held that "[w]here significant evidence does come to the attention of the district court that defendant has recently taken drugs, the court has the obligation to inquire further before determining that a competency hearing is not necessary." That court elaborated: "Rule 11 counsels a district court to make further inquiry into a defendant's competence to enter a guilty plea once the court has been informed that the defendant has recently ingested drugs or other substances capable of impairing his ability to make a knowing and intelligent waiver of his constitutional rights." Id. at 46. The First Circuit reached the same conclusion in United States v. Parra-Ibanez, 936 F.2d 588 (1st Cir. 1991). That court explained:

the district court had reason to suspect that the medications taken by the accused might impinge upon the accused's capacity to enter a voluntary and intelligent plea. At the outset of the Rule 11 hearing, Parra confirmed the district judge's understanding that he had "been under the care of a doctor for a mental or emotional condition." And Parra advised the judge that in that connection he had, within the previous twenty-four hours, taken three medications-Ativan, Halcion and Restoril. Parra affirmed that, as the judge supposed, "Ativan . . . is . . . a drug to control your nerves or something." Although the judge's further questions did elicit (1) from Parra assurances that he understood the proceedings and knew that a maximum sentence of forty years could be imposed, and (2) from defense counsel and prosecutor their joint assurance that appellant was competent to plead guilty, the judge did not inquire what dosages of Ativan, Halcion and Restoril Parra had ingested and what effects, if any, such medications might be likely to have on Parra's clear-headedness. The judge, though plainly making a substantial inquiry, did not probe deeply enough.

Id. at 595-96. The First Circuit recently reaffirmed this standard. See Miranda-Gonzalez v. United States, 181 F.3d 164 (1st Cir. 1999) (concluding that it was unnecessary for district court to inquire further about defendant's recent ingestion of drugs when the court had already asked detailed follow-up questions required by Parra Ibanez about the type of drugs taken, the frequency and quantity of doses, and their effects on defendant's cognitive functions).3

Here, as in Parra-Ibanez, the district court was put on direct notice that Damon could be under the influence of...

To continue reading

Request your trial
49 cases
  • State v. Lawson
    • United States
    • Ohio Supreme Court
    • October 7, 2021
    ...in State v. Montgomery , relying on State v. Mink , 101 Ohio St.3d 350, 2004-Ohio-1580, 805 N.E.2d 1064, ¶ 66, and United States v. Damon , 191 F.3d 561, 565 (4th Cir.1999), squarely addressed this point:The majority seems to be satisfied that [appellant, Caron Montgomery,] stated in open c......
  • State v. Mink, 101 Ohio St.3d 350 (Ohio 4/14/2004)
    • United States
    • Ohio Supreme Court
    • April 14, 2004
    ...a defendant seeking to enter a guilty plea has stated that he is under the influence of drugs or medication. See United States v. Damon (C.A.4, 1999), 191 F.3d 561, 565; United States v. Cole (C.A.3, 1987), 813 F.2d 43, 47; United States v. Parra-Ibanez (C.A.1, 1991), 936 F.2d 588, 595; cf.......
  • U.S. v. Moussaoui
    • United States
    • U.S. Court of Appeals — Fourth Circuit
    • January 4, 2010
    ...plea. "Before a court may accept a guilty plea, it must ensure that the defendant is competent to enter the plea." United States v. Damon, 191 F.3d 561, 564 (4th Cir.1999). The standard for competence to plead guilty is the same as that for competence to stand trial: whether the defendant "......
  • State v. Montgomery
    • United States
    • Ohio Supreme Court
    • August 24, 2016
    ...Id. at ¶ 66–68. In the present case, no competency evaluation was ever performed on Montgomery.{¶ 196} Similarly, in United States v. Damon, 191 F.3d 561 (4th Cir.1999), which this court cited in Mink, the federal court held that the trial court had "failed to inquire about what effect, if ......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT